Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07406022

Optical Characterization and Multi-modality, Multi-scale Modeling of Human Skin Applied to Cancer Diagnosis.

Skin carcinomas are the most commonly diagnosed cancers in fair-skinned populations, for example in France, Western Europe, and North America in particular. The OpticSkin project will build and make available to the general public and the scientific and medical community a histological and optical spectroscopic database of healthy, precancerous, and cancerous human skin in terms of absorption, elastic and inelastic scattering (Raman), steady-state and time-resolved autofluorescence, and polarization. The aim is to identify spectroscopic signatures that will be useful for diagnosis.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHR Metz-Thionville

Metz, 57085, France

Location status: Recruiting

About this study

The Priority Research Program and Equipment for Light-Matter (PEPR LUMA) has granted its support to the OpitcSkin project, which aims to provide diagnostic information that complements that currently provided by histology for the diagnosis of skin carcinomas, the most common cancers among fair-skinned populations. In recent years, several imaging and optical spectroscopy modalities have been evaluated in vivo in clinical settings to quantify the real-time diagnostic assistance they provide to clinicians performing surgical resection of skin carcinomas. Imaging methods such as confocal reflectance microscopy, optical coherence tomography, and nonlinear optical microscopy provide morphological information that improves diagnostic accuracy and reduces the risk of recurrence by allowing immediate verification after surgery that the tumor has been completely removed.

Spectroscopic methods, including Raman spectroscopy and autofluorescence, which are also applied in vivo, provide additional structural and functional information, for example on metabolism, further improving diagnostic accuracy. In all cases, studies have shown that combining multiple optical imaging and/or spectroscopy modalities, as well as data analysis and/or machine learning methods, offers better diagnostic accuracy than each modality taken individually.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with skin carcinomas and actinic keratoses

Exclusion criteria

  • minor patient

Treatment and study plan

Primary outcomes

  1. automated recognition

    Time frame: Until the end of the study on average 2 years

    automated recognition (by supervised classification) of optical data acquired on different histological classes

Study contacts

Contact information is provided by the study sponsor or research team.

Andreia CARVALHO DE FREITAS

CONTACT

[email protected]

0033387553323

Grégoire Khairallah

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Régional Metz-Thionville

Other

Registry information

Acronym: OpticSkin

Important dates

Study start
2025
Primary completion
2029
Study completion
2029
First posted
Feb 12, 2026
Registry last updated
Jun 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.